India's Pharmaceutical Exports

Country Profile

Cameroon

Cameroon is a growing market for Indian pharmaceuticals — $85.1M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 90% of shipments, with vaccines contributing $6.42M. The compound annual growth rate since FY2015 stands at 4.5%.

🇨🇲 $85.1M · 1.6× growth since FY2015 · 4.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$85.1M
Exports FY2025–26 DGCIS
1.6×
Growth FY2015→2026
4.5%
CAGR FY2015→2026
90%
Medicines Share
5
Product Categories Supplied
Cameroon is a growing market for Indian pharmaceuticals — $85.1M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 90% of shipments, with vaccines contributing $6.42M. The compound annual growth rate since FY2015 stands at 4.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $76.4M (89.8%) Vaccines $6.42M (7.5%) Medicine Ingredients $1.78M (2.1%) Surgical & Hospital Supplies $369K (0.4%) Traditional & Herbal $125K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Cameroon in the RBI overseas direct investment dataset (2011–2026).